$2.51T
Total marketcap
$69.83B
Total volume
BTC 50.47%     ETH 15.11%
Dominance

National Research Corporation NR1A.SG Stock

31.8 EUR {{ price }} -1.851859% {{change_pct}}%
COUNTRY
Germany
Exchange
Stuttgart
Market Cap
758.89M EUR
LOW - HIGH [24H]
31.6 - 31.8 EUR
VOLUME [24H]
0 EUR
{{ volume }}
P/E Ratio
27.41
Earnings per share
1.16 EUR

National Research Corporation Price Chart

National Research Corporation NR1A.SG Financial and Trading Overview

National Research Corporation stock price 31.8 EUR
Previous Close 40.2 EUR
Open 40 EUR
Bid 40 EUR x N/A
Ask 42 EUR x N/A
Day's Range 40 - 40 EUR
52 Week Range 32.2 - 43 EUR
Volume 0 EUR
Avg. Volume 0 EUR
Market Cap 1.01B EUR
Beta (5Y Monthly) 0.519718
PE Ratio (TTM) 35.714287
EPS (TTM) 1.16 EUR
Forward Dividend & Yield 0.58 (1.41%)
Ex-Dividend Date June 29, 2023
1y Target Est N/A

NR1A.SG Valuation Measures

Enterprise Value 849.1M EUR
Trailing P/E 35.714287
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 6.776925
Price/Book (mrq) 13.170893
Enterprise Value/Revenue 5.676
Enterprise Value/EBITDA 17.252

Trading Information

National Research Corporation Stock Price History

Beta (5Y Monthly) 0.519718
52-Week Change 19.52%
S&P500 52-Week Change 20.43%
52 Week High 43 EUR
52 Week Low 32.2 EUR
50-Day Moving Average 39.28 EUR
200-Day Moving Average 38.4 EUR

NR1A.SG Share Statistics

Avg. Volume (3 month) 0 EUR
Avg. Daily Volume (10-Days) 0 EUR
Shares Outstanding 24.61M
Float 14.38M
Short Ratio N/A
% Held by Insiders 42.09%
% Held by Institutions 47.70%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0.72
Trailing Annual Dividend Yield 1.79%
5 Year Average Dividend Yield 136.00%
Payout Ratio 0.595
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 20.20%
Operating Margin (ttm) 29.32%
Gross Margin 62.19%
EBITDA Margin 32.89%

Management Effectiveness

Return on Assets (ttm) 19.07%
Return on Equity (ttm) 38.71%

Income Statement

Revenue (ttm) 149.6M EUR
Revenue Per Share (ttm) 6.04 EUR
Quarterly Revenue Growth (yoy) -5.099%
Gross Profit (ttm) 94.52M EUR
EBITDA 49.22M EUR
Net Income Avi to Common (ttm) 30.21M EUR
Diluted EPS (ttm) 1.12
Quarterly Earnings Growth (yoy) -18.39%

Balance Sheet

Total Cash (mrq) 23.72M EUR
Total Cash Per Share (mrq) 0.97 EUR
Total Debt (mrq) 21.76M EUR
Total Debt/Equity (mrq) 29.14 EUR
Current Ratio (mrq) 1.251
Book Value Per Share (mrq) 3.037

Cash Flow Statement

Operating Cash Flow (ttm) 35.73M EUR
Levered Free Cash Flow (ttm) 17.66M EUR

Profile of National Research Corporation

Country Germany
State NE
City Lincoln
Address 1245 Q Street
ZIP 68508
Phone 402 475 2525
Website https://nrchealth.com
Industry Health Information Services
Sector(s) Healthcare
Full Time Employees 491

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, health risk assessments, employee engagement, reputation management, and brand loyalty. The company also offers market insights solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient experience, workforce engagement, health risk assessments, care transition, and improvement tools. Further, the company provides reputation solutions that allow healthcare organizations to share a picture of their organization and ensure that timely and relevant content informs consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.

Q&A For National Research Corporation Stock

What is a current NR1A.SG stock price?

National Research Corporation NR1A.SG stock price today per share is 31.8 EUR.

How to purchase National Research Corporation stock?

You can buy NR1A.SG shares on the Stuttgart exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for National Research Corporation?

The stock symbol or ticker of National Research Corporation is NR1A.SG.

Which industry does the National Research Corporation company belong to?

The National Research Corporation industry is Health Information Services.

How many shares does National Research Corporation have in circulation?

The max supply of National Research Corporation shares is 23.86M.

What is National Research Corporation Price to Earnings Ratio (PE Ratio)?

National Research Corporation PE Ratio is 27.41379400 now.

What was National Research Corporation earnings per share over the trailing 12 months (TTM)?

National Research Corporation EPS is 1.16 EUR over the trailing 12 months.

Which sector does the National Research Corporation company belong to?

The National Research Corporation sector is Healthcare.